Daratumumab-225Actinium conjugate demonstrates greatly enhanced antitumor activity against experimental multiple myeloma tumors

DOI: 10.1080/2162402X.2019.1607673

Keywords: Multiple myeloma, daratumumab, 225Actinium, microSPECT/CT, radioimmunotherapy

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text